{
    "pmcid": "11133524",
    "qa_pairs": {
        "What challenge is associated with the humanization of nanobodies compared to conventional antibodies?": [
            "Nanobodies have distinct structural features that make direct application of antibody-focused humanization tools challenging.",
            "Nanobodies are more prone to aggregation during the humanization process.",
            "Nanobodies require more complex computational models for humanization.",
            "Nanobodies have a lower initial binding affinity that complicates humanization efforts."
        ],
        "What does the paper suggest is needed for improving the reliability of computational humanization tools for nanobodies?": [
            "More robust validation methods and comprehensive datasets.",
            "Increased funding for computational tool development.",
            "Collaboration with pharmaceutical companies for real-world testing.",
            "Integration of more advanced machine learning algorithms."
        ],
        "What is the function of the computational tool Llamanade in the context of nanobody humanization?": [
            "It focuses on maintaining key physicochemical properties while increasing humanness.",
            "It predicts the binding affinity of nanobodies to the SARS-CoV-2 spike protein.",
            "It enhances the solubility of nanobodies during the humanization process.",
            "It reduces the production cost of nanobodies by optimizing expression systems."
        ],
        "What is the primary goal of humanizing therapeutic antibodies according to the paper?": [
            "To reduce immunogenicity by increasing similarity to human antibodies.",
            "To enhance the binding affinity to target antigens.",
            "To improve the structural stability of antibodies.",
            "To decrease the production cost of antibodies."
        ],
        "Why are nanobodies considered promising therapeutic agents for targeting the SARS-CoV-2 spike protein?": [
            "Their small size enhances expression, tumor penetration, and solubility while maintaining high binding affinity.",
            "They have a higher natural affinity for the SARS-CoV-2 spike protein than conventional antibodies.",
            "They are less expensive to produce than conventional antibodies.",
            "They are naturally resistant to degradation by human enzymes."
        ]
    }
}